Conclusion:
MR imaging-guided breast biopsy was canceled due to lesion nonvisualization in 8% of the patients. Although the cancer detection rate among the lesions for which biopsy was canceled is low (95% CI: 0%, 9%), short-term follow-up MR imaging is prudent.
© RSNA, 2011 (Source: Continuous Publishing articles)
View full post on MedWorm: HIPAA
Posts Tagged ‘Followup’
Cancellation of MR Imaging-guided Breast Biopsy Due to Lesion Nonvisualization: Frequency and Follow-Up [Breast Imaging]
Chemoembolization Follow-up of Hepatocellular Carcinoma with MR Imaging: Usefulness of Evaluating Enhancement Features on One-month Posttherapy MR Imaging for Predicting Residual Disease
Conclusions: This investigation shows high accuracy for using tumor enhancement features on 1-month posttherapy MR imaging to predict residual disease after chemoembolization of HCC. (Source: Journal of Vascular and Interventional Radiology : JVIR)
View full post on MedWorm: HIPAA